Cimzia (Certolizumab Pegol) Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Project
The purpose of the OTIS Autoimmune Diseases in Pregnancy Project, Cimzia Pregnancy Exposure
Registry is to follow pregnant women with or without rheumatoid arthritis (RA) or Crohn's
Disease (CD) who have or have not been treated with Cimzia during pregnancy to evaluate the
possible effect of these diseases, and or this medication on the pregnancy outcome including
child development and growth up to five years of age.
Observational Model: Cohort, Time Perspective: Prospective
The primary objective of the study is to evaluate the effect of certain medications when used in the first trimester of pregnancy with respect to major structural birth defects.
Duration of pregnancy and up to 1 year of life
Christina Chambers, PhD
University of California, San Diego
United States: Institutional Review Board
|University of California, San Diego||La Jolla, California 92037-1709|